Quantum Capital Management (California)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$157K Sell
697
-174
-20% -$36.1K 0.18% 84
2020
Q2
$152K Sell
871
-327
-27% -$52.2K 0.09% 126
2020
Q1
$151K Sell
1,198
-111
-8% -$16.6K 0.1% 137
2019
Q4
$200K Sell
1,309
-176
-12% -$24.4K 0.1% 138
2019
Q3
$197K Buy
+1,485
New +$199K 0.1% 150

Other funds holding CRL

Quantum Capital Management (California)'s CRL Position: Q3 2020 in Review

Quantum Capital Management (California) reduced its Charles River Laboratories (CRL) stake by 20% in Q3 2020, selling an estimated $36.1K and leaving 697 shares worth $157K. The position accounts for 0.18% of the portfolio, ranked #84.

Quantum Capital Management (California) first reported a position in CRL in Q3 2019 and has held it in 5 quarters since. The position peaked at $200K in Q4 2019. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • Quantum Capital Management (California) held 697 shares of Charles River Laboratories worth $157K as of Q3 2020.
  • Quantum Capital Management (California) sold 174 Charles River Laboratories shares in Q3 2020, an estimated $36.1K.
  • Charles River Laboratories made up 0.18% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #84 holding.
  • Quantum Capital Management (California) first reported a position in Charles River Laboratories in Q3 2019 and has held it in 5 quarters since.
  • Quantum Capital Management (California)'s Charles River Laboratories position peaked at $200K in Q4 2019.
  • 492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.